Institute

Back to overview
Name

Paul Scherrer Institut

Address Paul Scherrer Institut

5232
CH-Villigen PSI
Website http://zrw.web.psi.ch/
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Systematic nuclide therapy with recombinant 67-Cu-labeled chCE7 antibodies: Therapeutic efficacy and investigations of tumor responses with PET imaging.
Novak-Hofer Ilse Paul Scherrer Institute - PSI 01.06.2003 31.05.2006 Project funding (Div. I-III)

Experimental evaluation of the diagnostic and therapeutic potential of biosynthetically radiolabeled monoclonal anti- bodies
Ryser Jean-Etienne Paul Scherrer Institute - PSI 01.10.1987 30.09.1989 Project funding (Div. I-III)

Investigation of a New Class of Folate-Based RadioImaging Agents and RadioTherapeutics
Müller Cristina Paul Scherrer Institute - PSI 01.02.2020 31.01.2024 Project funding (Div. I-III)

Monoclonal antibodies labeled biosynthetically by Se-75- selenomethionine: study of their potential use in medical diagnosis.
Ryser Jean-Etienne Paul Scherrer Institute - PSI 01.10.1985 30.09.1987 Project funding (Div. I-III)

Investigation of putative neurotoxicity of MDMA (Ecstasy) in humans by PET and the radioligand McN-5652
Schubiger Pius August Paul Scherrer Institute - PSI 01.04.1998 31.03.2001 Project funding (Div. I-III)

Design and synthesis of ligands which recognize and selectively bind to Z-DNA
Alberto Roger Paul Scherrer Institute - PSI 01.04.2001 31.03.2003 Project funding (Div. I-III)

The biodistribution and catabolism of radiolabelled monoclonal antibodies in normal and in tumor-bearing mice
Ryser Jean-Etienne Paul Scherrer Institute - PSI 01.10.1989 30.09.1991 Project funding (Div. I-III)

Development of New Folate-Based RadioImaging Agents and RadioTherapeutics
Müller Cristina Paul Scherrer Institute - PSI 01.04.2015 31.07.2018 Project funding (Div. I-III)

The biodistribution and catabolism of radiolabelled monoclonal antibodies in normal and in tumor-bearing mice
Ryser Jean-Etienne Paul Scherrer Institute - PSI 01.10.1991 31.05.1994 Project funding (Div. I-III)

Innovative peptidic radiotracer for targeting structures of extra-cellular matrix in different diseases
Behe Martin Paul Scherrer Institute - PSI 01.09.2018 31.08.2022 Project funding (Div. I-III)

Combination of radioimmunotherapy with growth inhibition for antibody-based therapy of L1 expressing metastases
Novak-Hofer Ilse Paul Scherrer Institute - PSI 01.05.2007 30.09.2008 Project funding (Div. I-III)

Folate Receptor Targeting for Imaging and Potential Therapy of Cancerous and Inflammatory Diseases
Müller Cristina Paul Scherrer Institute - PSI 01.02.2012 31.01.2013 Ambizione

Development of the nuclear medicine tracer 76Br-bromo-deoxy- uridine for the measurement of DNA synthesis by imaging
Schubiger Pius August Paul Scherrer Institute - PSI 01.04.1996 31.12.1996 Project funding (Div. I-III)

Improving the Efficacy and Quality of Immunoconjugates Using Novel Enzymatic Methods for the Site-specific and Stoichiometric Modification of Proteins
Schibli Roger Paul Scherrer Institute - PSI 01.04.2011 31.03.2014 Project funding (Div. I-III)

Development of a Radioligand for ACE2 PET Imaging - A Tool to Investigate the Expression and Regulation of the SARS-CoV-2 Entry Receptor
Müller Cristina Paul Scherrer Institute - PSI 01.10.2020 30.09.2022 NRP 78 Covid-19

111-Silver labelling of monoclonal antibodies to produce selective cytotoxic agents
Smith Alan Paul Scherrer Institute - PSI 01.04.1991 31.07.1994 Project funding (Div. I-III)

Spin lattice and electron lattice interactions in correlated quantum materials
Staub Urs Paul Scherrer Institute - PSI 01.07.2021 30.06.2024 Project funding (Div. I-III)

Folate Receptor Targeting for Imaging and Potential Therapy of Cancerous and Inflammatory Diseases
Müller Cristina Paul Scherrer Institute - PSI 01.02.2009 31.01.2012 Ambizione

Monoclonal antibodies labelled biosynthetically by 75-Se- selenomethionine: study in an animal model of their poten- tial use in medical diagnosis.
Ryser Jean-Etienne Paul Scherrer Institute - PSI 01.04.1984 30.09.1985 Project funding (Div. I-III)
-